High materiality9/10
Mirum Pharmaceuticals price target raised to $200 from $195 at H.C. Wainwright
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: price target raised to $200 for MIRM; current price $84.59; firm H.C. Wainwright.
- Target up; upside potential.
Key facts
- 01
Target: $200
- 02
Posted price: $84.59
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.